BioNTech counts on shift to cancer drugs after second quarter losses quadruple

Go back to BioNTech counts on shift to cancer drugs after second quarter losses quadruple
(NASDAQ: BNTX) Delayed: 90.54 +1.00 (1.12%)
Previous Close $89.54    52 Week High
Open $89.10    52 Week Low
Day High $90.68    P/E N/A 
Day Low $88.58    EPS
Volume 1,130,847